124 related articles for article (PubMed ID: 15390284)
1. Differences in pediatric oncologists' estimates of curability and treatment recommendations for patients with advanced cancer.
Wusthoff CJ; McMillan A; Ablin AR
Pediatr Blood Cancer; 2005 Feb; 44(2):174-81. PubMed ID: 15390284
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for advanced breast cancer: what influences oncologists' decision-making?
Grunfeld EA; Ramirez AJ; Maher EJ; Peach D; Young T; Albery IP; Richards MA
Br J Cancer; 2001 May; 84(9):1172-8. PubMed ID: 11336466
[TBL] [Abstract][Full Text] [Related]
3. Differences in pediatric oncologists' estimates of curability and treatment recommendations for patients with advanced cancer.
Cohen IJ; Yaniv I
Pediatr Blood Cancer; 2005 Sep; 45(3):357; author reply 358. PubMed ID: 16015603
[No Abstract] [Full Text] [Related]
4. Cost issues in new disease-modifying treatments for advanced cancer: in-depth interviews with physicians.
de Kort SJ; Kenny N; van Dijk P; Gevers S; Richel DJ; Willems DL
Eur J Cancer; 2007 Sep; 43(13):1983-9. PubMed ID: 17616456
[TBL] [Abstract][Full Text] [Related]
5. Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey.
Schrag D; Hanger M
J Clin Oncol; 2007 Jan; 25(2):233-7. PubMed ID: 17210946
[TBL] [Abstract][Full Text] [Related]
6. Desire for information and involvement in treatment decisions: elderly cancer patients' preferences and their physicians' perceptions.
Elkin EB; Kim SH; Casper ES; Kissane DW; Schrag D
J Clin Oncol; 2007 Nov; 25(33):5275-80. PubMed ID: 18024875
[TBL] [Abstract][Full Text] [Related]
7. Supportive versus palliative care: what's in a name?: a survey of medical oncologists and midlevel providers at a comprehensive cancer center.
Fadul N; Elsayem A; Palmer JL; Del Fabbro E; Swint K; Li Z; Poulter V; Bruera E
Cancer; 2009 May; 115(9):2013-21. PubMed ID: 19235253
[TBL] [Abstract][Full Text] [Related]
8. Oncologists' attitudes to treatment of cancer patients.
Gilbar O; Cohen BZ
Death Stud; 1995; 19(4):303-13. PubMed ID: 10160548
[TBL] [Abstract][Full Text] [Related]
9. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
Sneed RC; May WL; Stencel C
Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
[TBL] [Abstract][Full Text] [Related]
10. The think aloud method: a guide to user interface design.
Jaspers MW; Steen T; van den Bos C; Geenen M
Int J Med Inform; 2004 Nov; 73(11-12):781-95. PubMed ID: 15491929
[TBL] [Abstract][Full Text] [Related]
11. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling?
Söllner W; DeVries A; Steixner E; Lukas P; Sprinzl G; Rumpold G; Maislinger S
Br J Cancer; 2001 Jan; 84(2):179-85. PubMed ID: 11161373
[TBL] [Abstract][Full Text] [Related]
12. The use of palliative chemotherapy in pediatric oncology patients: a national survey of pediatric oncologists.
Kang TI; Hexem K; Localio R; Aplenc R; Feudtner C
Pediatr Blood Cancer; 2013 Jan; 60(1):88-94. PubMed ID: 23024072
[TBL] [Abstract][Full Text] [Related]
13. Integration of a palliative and terminal care center into a comprehensive pediatric oncology department.
Golan H; Bielorai B; Grebler D; Izraeli S; Rechavi G; Toren A
Pediatr Blood Cancer; 2008 May; 50(5):949-55. PubMed ID: 18240176
[TBL] [Abstract][Full Text] [Related]
14. The median informs the message: accuracy of individualized scenarios for survival time based on oncologists' estimates.
Kiely BE; Martin AJ; Tattersall MH; Nowak AK; Goldstein D; Wilcken NR; Wyld DK; Abdi EA; Glasgow A; Beale PJ; Jefford M; Glare PA; Stockler MR
J Clin Oncol; 2013 Oct; 31(28):3565-71. PubMed ID: 24002504
[TBL] [Abstract][Full Text] [Related]
15. Comparisons of patient and physician expectations for cancer survivorship care.
Cheung WY; Neville BA; Cameron DB; Cook EF; Earle CC
J Clin Oncol; 2009 May; 27(15):2489-95. PubMed ID: 19332716
[TBL] [Abstract][Full Text] [Related]
16. Evolving roles of oncology pharmacists in Singapore: a survey on prescribing patterns of antiemetics for chemotherapy induced nausea and vomiting (CINV) at a cancer centre.
Chan A; Shih V; Chew L
J Oncol Pharm Pract; 2008 Mar; 14(1):23-9. PubMed ID: 18337437
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists.
Hurria A; Naeim A; Elkin E; Limaye S; Grover A; Hudis C; Pearce C; Robson M
Crit Rev Oncol Hematol; 2007 Mar; 61(3):255-60. PubMed ID: 17098441
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?
Keating NL; Landrum MB; Klabunde CN; Fletcher RH; Rogers SO; Doucette WR; Tisnado D; Clauser S; Kahn KL
J Clin Oncol; 2008 May; 26(15):2532-7. PubMed ID: 18487570
[TBL] [Abstract][Full Text] [Related]
19. Telling their stories, telling our stories: physicians' experiences with patients who decide to forgo or stop treatment for cancer.
Madjar I; Kacen L; Ariad S; Denham J
Qual Health Res; 2007 Apr; 17(4):428-41. PubMed ID: 17416697
[TBL] [Abstract][Full Text] [Related]
20. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
